Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA)

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice